The company has said it expects the inoculation to be a major driver of future sales to offset the loss of patent protection for some of its key HIV medicines later this decade.
from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/UMqkcZm
Home »
Information and Updates: ET HealthWorld : ETHealthworld.com
,
Top Health News | Latest Healthcare Sector & Healthcare Industry news
» GSK expects RSV vaccine uptake will be slower than shingles vaccine-CEO
https://ift.tt/LWog6nu
No comments:
Post a Comment